Rare Disease Report

Hansa Medical AB

MAY 20, 2014
James Radke

Hansa Medical AB is a Swedish based company developing IdeS for its use in a number of rare conditions that can benefit for IdeS, an enzyme that targets specific igG antibodies. In this exclusive interview with Emanuel Björne, CEO of Hansa Medical AB, he explains the origins of company as well as the clinical trials they have planned and in development.

For more information about IdeS and Hansa Medical AB, visit www.hansamedical.com

Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.